[PDF][PDF] A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxì… - …, 2010 - Wiley Online Library
… that the survival rates of untreated patients or of those who received placebo in randomized
controlled trials (RCTs) of unresectable HCC vary among the studies, ranging from 10% to 72…

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer

RM Goldberg, DJ Sargent, RF Morton… - Journal of Clinical …, 2004 - ascopubs.org
study provides convincing evidence that FOLFOX is an active regimen for treatment of patients
with previously untreated … investigators from smaller phase III trials. Treatment with this …

… patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy: combined analysis of two randomized controlled studies

P Gibbs, V Heinemann, NK Sharma, J Taieb… - Clinical colorectal …, 2018 - Elsevier
… factor for patients with metastatic colorectal cancer (mCRC). We examined the survival data
from 2 randomized studies to determine whether the outcomes differ between patients with …

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

, … Network, Turkish Myeloma Study Group … - Blood, The Journal …, 2011 - ashpublications.org
… The role of thalidomide for previously untreated elderly patients with multiple myeloma
remains unclear. Six randomized controlled trials, launched in or after 2000, compared …

… efficacy of pathogen-reduced platelets vs untreated platelets in patients with thrombocytopenia and malignant hematologic diseases: a randomized clinical trial

F Garban, A Guyard, H Labussière, CE Bulabois… - JAMA …, 2018 - jamanetwork.com
… a randomized clinical trial to test … untreated platelets in plasma (PP) or to untreated platelets
in additive solution (P-PAS) with regard to hemostatic efficacy in minimally selected patients

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

JR Mendell, RJ Barohn, ML Freimer, JT Kissel, W King… - Neurology, 2001 - AAN Enterprises
patients by AMS in the current study exceeds previous estimates14 that two thirds of patients
… Our results justify the use of IVIg for the patient with untreated CIDP. A recommendation that …

Early interdisciplinary supportive care in patients with previously untreated metastatic esophagogastric cancer: a phase III randomized controlled trial

Z Lu, Y Fang, C Liu, X Zhang, X Xin, Y He… - Journal of Clinical …, 2021 - ascopubs.org
… Therefore, we prospectively conducted a randomized controlled trial to compare the clinical
… treatment in patients with previously untreated metastatic EGC. Patients and Methods …

Treatment of occult bacteremia: a prospective randomized clinical trial

WL Carroll, MK Farrell, JI Singer, MA Jackson… - …, 1983 - publications.aap.org
Antibiotic therapy for children without foci of infection and at risk for bacteremia is controversial.
A prospective randomized clinical trial was conducted using expectant antibiotic therapy …

Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial

PF van der Meer, PF Ypma… - Blood, The Journal …, 2018 - ashpublications.org
trials, we conducted a noninferiority randomized controlled trial comparing pathogen-inactivated
platelet concentrates using the Mirasol technology with conventional untreated platelet …

Systemic therapy for previously untreated advanced BRAF-mutated melanoma: a systematic review and network meta-analysis of randomized clinical trials

T Devji, O Levine, B Neupane, J Beyene, F Xie - JAMA oncology, 2017 - jamanetwork.com
… We limited our search to randomized clinical trials (RCTs) by applying a filter developed
by the Health Information Research Unit at McMaster University. There were no language or …